ALLMedicine™ Radical Hysterectomy Center
Research & Reviews 1,047 results
https://doi.org/10.1186/s12905-022-01826-7 10.3322/caac.21492 10.3322/caac.21338 10.6004/jnccn.2020.0027 10.1007/s11864-015-0386-9 10.1097/IGC.0000000000000991 10.1016/j.ygyno.2022.01.023 10.1136/ijgc-2019-000398 10.1136/ijgc-2021-003297 10.1016/j.fertnstert.2020.02.003 10.1097/AOG.0000000000003952 10.1056/NEJMoa1806395 10.1002/ijgo.12611 10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W 10.1016/j.ygyno.2016.01.028 10.1016/j.ygyno.2015.06.023 10.1097/IGC.0000000000000763 10.1016/j.ygyno.2013.07.108 10.1016/j.ygyno.2011.01.032 10.1016/j.ygyno.2005.07.071 10.1097/IGC.0000000000000031 10.1016/j.ygyno.2011.09.035 10.1002/jso.23631 10.1016/j.fertnstert.2013.12.001 10.1016/j.ygyno.2008.08.023 10.1007/s43032-021-00807-9 10.3390/cancers14030797
BMC Women's Health; He Z, Bian C et. al.
Jun 19th, 2022 - Radical trachelectomy is an acceptable alternative to radical hysterectomy for patients with early-stage cervical cancer who wish to preserve reproductive function. This study is designed to compare the laparoscopic versus abdominal radical trache...
https://doi.org/10.1007/s10147-022-02198-6 10.3322/caac.21660 10.1016/S0140-6736(97)02250-2 10.1016/j.ygyno.2016.11.034 10.1097/IGC.0000000000000202 10.1093/jjco/hyz200 10.1016/j.ygyno.2020.07.023 10.1001/jamanetworkopen.2020.4307 10.1006/gyno.1999.5387 10.1007/s10147-018-1351-y 10.1200/JCO.2000.18.8.1606 10.18632/oncotarget.22437 10.1007/s10147-021-01938-4 10.1002/ijgo.12749 10.3802/jgo.2017.28.e19 10.1016/j.ygyno.2014.01.043 10.1016/j.ijrobp.2011.12.013 10.1371/journal.pone.0144887 10.1620/tjem.255.303 10.1016/j.ejso.2017.01.017 10.1111/jog.14953 10.1016/j.ygyno.2005.10.004 10.1245/s10434-013-3067-6 10.1097/AOG.0000000000003280 10.1016/j.ygyno.2021.06.026 10.1136/ijgc-2020-001974 10.1016/j.ygyno.2004.03.011 10.1097/IGC.0b013e31828703fd 10.3802/jgo.2020.31.e35 10.2147/OTT.S158214 10.3802/jgo.2021.32.e44 10.1093/jjco/hyw145 10.3892/mco.2013.112 10.1111/jog.13282 10.1136/ijgc-2020-002344 10.1002/ijc.30793 10.1016/j.ijgo.2009.02.012 10.1016/S0020-7292(98)00234-3 10.1016/j.ygyno.2012.06.021 10.1006/gyno.1999.5442 10.1016/j.ajog.2016.04.023
International Journal of Clinical Oncology; Shigeta S, Shimada M et. al.
Jun 15th, 2022 - Adjuvant therapy is usually considered for surgically treated patients with uterine cervical cancer harboring intermediate risk (IR) factors such as large tumor diameter, stromal invasion to the outer half, and lymphovascular space invasion (LVSI)...
https://clinicaltrials.gov/ct2/show/NCT02613286
Jun 15th, 2022 - The purpose of this study is to evaluate the safety and efficacy of extrafascial hysterectomy compared with modified radical hysterectomy, both plus level 1 pelvic lymph-node dissection, in patients with early stage IA2-IB1 cervical cancer ≤ 2cm. ...
https://clinicaltrials.gov/ct2/show/NCT05410444
Jun 8th, 2022 - In this study, patients with postoperative radiotherapy for cervical cancer complicated with voiding dysfunction in the Department of gynecology and oncology radiotherapy of our hospital from July 2018 to December 2020 were selected as the researc...
https://doi.org/10.1080/01443615.2022.2069482
Journal of Obstetrics and Gynaecology : the Journal of Th... Ayhan S, Akar S et. al.
Jun 7th, 2022 - We investigated the association between preoperative ratios of inflammatory markers and the prognosis in patients with invasive cervical cancer (CC). In this single-centre study, we retrospectively enrolled 163 CC patients who underwent radical hy...
Clinicaltrials.gov 95 results
https://clinicaltrials.gov/ct2/show/NCT02613286
Jun 15th, 2022 - The purpose of this study is to evaluate the safety and efficacy of extrafascial hysterectomy compared with modified radical hysterectomy, both plus level 1 pelvic lymph-node dissection, in patients with early stage IA2-IB1 cervical cancer ≤ 2cm. ...
https://clinicaltrials.gov/ct2/show/NCT05410444
Jun 8th, 2022 - In this study, patients with postoperative radiotherapy for cervical cancer complicated with voiding dysfunction in the Department of gynecology and oncology radiotherapy of our hospital from July 2018 to December 2020 were selected as the researc...
https://clinicaltrials.gov/ct2/show/NCT05267834
May 27th, 2022 - The incidence of cervical cancer in developed countries declined considerably in the last few decades. This has been possible for efficient screening programs to which HPV vaccines have been added over the past 15 years. Despite this global reduct...
https://clinicaltrials.gov/ct2/show/NCT01101451
May 24th, 2022 - PRIMARY OBJECTIVE: I. To determine if post-operative adjuvant chemo-radiation therapy (CRT) can significantly improve recurrence-free survival (RFS) when compared to radiation therapy (RT) alone in stage I-IIA cervical cancer patients with interme...
https://clinicaltrials.gov/ct2/show/NCT01048853
May 2nd, 2022 - PRIMARY OBJECTIVE: I. To evaluate the safety and feasibility of performing conservative surgery in women with stage IA2 or IB1 carcinoma of the cervix with favorable pathologic features. SECONDARY OBJECTIVES: I. To estimate the cervix cancer recur...
News 60 results
https://www.mdedge.com/obgyn/article/243279/gynecologic-cancer/advice-biopsies-workups-and-referrals
Emma Rossi, MD
Jul 23rd, 2021 - Over the next 2 months we will dedicate this column to some general tips and pearls from the perspective of a gynecologic oncologist to guide general obstetrician gynecologists in the workup and management of preinvasive or invasive gynecologic di.
https://www.medpagetoday.com/hematologyoncology/cervicalcancer/92320
Apr 28th, 2021 - Use of a minimally invasive approach to hysterectomy for early cervical cancer decreased substantially after a clinical trial showed the procedure may actually cause harm, researchers found. Following publication of the Laparoscopic Approach to Ce...
https://www.mdedge.com/obgyn/article/239077/gynecologic-cancer/surgery-early-stage-cervical-cancer-are-we-still-too-radical
Emma Rossi, MD
Apr 23rd, 2021 - It has been more than 120 years since Ernst Wertheim, a Viennese surgeon, performed and described what is considered to have been the first radical total hysterectomy with lymphadenectomy for early-stage cervical cancer, yet this morbid procedure.
https://www.mdedge.com/hematology-oncology/article/237455/gynecologic-cancer/delaying-surgery-didnt-impact-survival-early
M. Alexander Otto
Mar 21st, 2021 - Delaying surgery for up to 3 months had no adverse impact on overall survival in early-stage cervical cancer in a retrospective study of more than 4,700 women in the National Cancer Database. Dr.
https://www.onclive.com/view/how-is-treatment-changing-for-patients-with-cervical-cancer-three-experts-weigh-in
Dec 5th, 2020 - Richard T. Penson, MD Associate Professor Harvard Medical School Clinical Director, Medical and Gynecological Oncology Massachusetts General Hospital Boston, MA Q: We know that cisplatin and radiotherapy has been a standard of care in ...
